|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
77,230,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0 - $0 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Applied Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of product candidates against validated molecular targets in indications of high unmet medical need. AT-007 is a central nervous system penetrant ARI that Co. is developing for the treatment of metabolic diseases, including Galactosemia, a pediatric metabolic disease that affects how the body processes a simple sugar called galactose. AT-001 is an ARI with systemic exposure and peripheral nerve permeability that Co. is developing for the treatment of diabetic cardiomyopathy. AT-003 is an ARI designed to cross through the back of the eye when dosed orally for the treatment of diabetic retinopathy.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
30,000 |
30,000 |
3,691,409 |
Total Buy Value |
$0 |
$65,367 |
$65,367 |
$3,658,451 |
Total People Bought |
0 |
1 |
1 |
3 |
Total Buy Transactions |
0 |
1 |
1 |
5 |
Total Shares Sold |
506,975 |
513,491 |
1,224,775 |
1,252,098 |
Total Sell Value |
$2,732,596 |
$2,745,433 |
$4,466,825 |
$4,492,358 |
Total People Sold |
4 |
4 |
6 |
7 |
Total Sell Transactions |
4 |
7 |
14 |
18 |
End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Shendelman Shoshana |
President and CEO |
|
2020-07-08 |
4 |
AS |
$32.21 |
$484,775 |
D/D |
(15,000) |
554,285 |
|
- |
|
Shendelman Shoshana |
President and CEO |
|
2020-07-08 |
4 |
OE |
$1.44 |
$21,600 |
D/D |
15,000 |
569,285 |
|
- |
|
Shendelman Shoshana |
President and CEO |
|
2020-07-07 |
4 |
AS |
$31.63 |
$482,513 |
D/D |
(15,000) |
554,285 |
|
- |
|
Shendelman Shoshana |
President and CEO |
|
2020-07-07 |
4 |
OE |
$1.44 |
$21,600 |
D/D |
15,000 |
569,285 |
|
- |
|
154 Records found
|
|
Page 7 of 7 |
|
|